Nearly 50 years of pulse-processing heritage. Three facilities across North America. Premium lentils, peas and plant proteins exported to more than 35 countries, feeding people and pets around the world.
Q1 2026 marked a clear inflection point: positive Adjusted EBITDA, expanding margins, and a net loss cut by more than half, with every filing now current.
Adjusted EBITDA(1), up 49% from $529,968 in Q1 2025.
Gross margin expanded 420 basis points from 11.5% a year earlier.
Net loss reduced to $1.31M from $3.28M in Q1 2025.
Cash at quarter end, nearly 3× the $2.03M held a year earlier.
(1) Non-IFRS measure. See the Q1 2026 news release for the reconciliation to IFRS measures.
Founded in 1978 and 100% owned by Eat Well Group, Belle Pulses transforms yellow and green peas into clean-label whole foods and functional ingredients trusted by global food brands.
A leading agribusiness platform capturing the value chain from farm to market, anchored by 3,000+ farmer relationships in a politically stable, geographically advantaged region.
Demonstrated scale and distribution across 35+ countries, serving world-class B2B customers including Nestlé, General Mills and Ingredion.
Positioned in the $449B food-ingredients market and heavily indexed to its fastest-growing segment: plant protein, projected to reach $162B by 2030.
Pulses are shelf-stable, water-efficient and soil-enriching, directly in the path of government policy momentum on both sides of the border, including billions earmarked for sustainable agriculture.
A leadership team of proven operators who conceived, built and sold Verdient Foods to Ingredion (NYSE: INGR), and have helped raise over $250M across ag, wellness and CPG.
Insiders, management and employees hold 49.4% of the company on a fully diluted basis. When shareholders win, we win.
Our ambition is straightforward: take Belle's winning model and replicate it at scale, becoming the number-one pulse processor in North America.
Three high-capacity facilities, each with expansion-ready land to scale production.
Active expansion into Europe, Asia and South America to meet rising international demand.
Decades of proprietary seed genetics, trade secrets and processing IP, a moat that commands premium pricing.
Category-leading innovation across human and pet food, unlocking premium product lines.
High-impact acquisitions at sector inflection points: scalable platforms with resilient margins.
The BCSC and OSC issued a full revocation on July 15, 2026. Trading on the CSE anticipated to recommence as soon as practicable.
Read the release → June 1, 2026Adjusted EBITDA of $790,313, gross profit expands 420 basis points, net loss cut by more than half.
Read the release → May 6, 2026Application submitted to the BCSC and OSC for full revocation of the CTO and resumption of trading on the CSE.
Read the release →Join Eat Well's investor mailing list for financial results, regulatory milestones and operational updates, straight from the company.